Pacira BioSciences, Inc.
PCRX
$25.17
$0.722.95%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 51.47% | 73.96% | 92.96% | 83.10% | 87.29% |
| Total Receivables | 3.35% | 7.41% | 3.69% | 4.80% | 8.46% |
| Inventory | 38.20% | 20.06% | 15.90% | 12.27% | 4.09% |
| Prepaid Expenses | 46.71% | 0.12% | 28.31% | 20.20% | 21.97% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 42.86% | -- | -- | -- |
| Total Current Assets | 39.93% | 46.11% | 54.27% | 47.26% | 44.40% |
|
|
|||||
| Total Current Assets | 39.93% | 46.11% | 54.27% | 47.26% | 44.40% |
| Net Property, Plant & Equipment | -7.49% | -7.90% | -7.73% | -8.54% | -7.72% |
| Long-term Investments | -86.82% | -- | -- | 0.00% | 0.00% |
| Goodwill | -86.82% | -- | -- | 0.00% | 0.00% |
| Total Other Intangibles | -7.24% | -11.85% | -11.51% | -11.19% | -10.89% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -8.54% | -9.36% | -11.63% | -13.45% | -15.82% |
| Total Assets | 0.21% | -1.33% | -0.83% | 6.77% | 3.93% |
|
|
|||||
| Total Accounts Payable | 157.98% | 21.88% | 17.30% | -22.62% | -47.96% |
| Total Accrued Expenses | 19.83% | 24.76% | 27.54% | 15.28% | 8.41% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1,098.66% | 1,107.79% | 1,120.07% | -67.88% | -10.91% |
| Total Finance Division Other Current Liabilities | -- | 24.43% | -- | -- | -- |
| Total Other Current Liabilities | -- | 24.43% | -- | -- | -- |
| Total Current Liabilities | 236.81% | 218.25% | 227.14% | -14.89% | -5.32% |
|
|
|||||
| Total Current Liabilities | 236.81% | 218.25% | 227.14% | -14.89% | -5.32% |
| Long-Term Debt | -25.48% | -25.35% | -25.21% | 10.73% | -5.75% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -16.72% | -18.54% | -16.14% | -16.49% | -16.01% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 44.21% | -3.17% | -11.81% | 6.44% | -34.56% |
| Total Liabilities | 14.03% | 10.07% | 9.84% | 4.51% | -8.50% |
|
|
|||||
| Common Stock & APIC | 3.44% | 3.36% | 3.45% | 3.42% | 5.70% |
| Retained Earnings | -106.04% | -93.22% | -68.91% | 44.62% | 41.87% |
| Treasury Stock & Other | -15,738.16% | -10,131.58% | -244,330.00% | -14,360.12% | 210.95% |
| Total Common Equity | -10.49% | -10.55% | -9.86% | 8.82% | 16.16% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -10.49% | -10.55% | -9.86% | 8.82% | 16.16% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -10.49% | -10.55% | -9.86% | 8.82% | 16.16% |
|
|
|||||